Holders over time
- CVS
- PM
| Quarter | CVS | PM |
|---|---|---|
| Q3 2020 | 29 holders, $8.9bn | 25 holders, $19.7bn |
| Q4 2020 | 22 holders, $9.8bn | 25 holders, $21.5bn |
| Q1 2021 | 28 holders, $10.3bn | 27 holders, $22.1bn |
| Q2 2021 | 24 holders, $11.8bn | 20 holders, $23.2bn |
| Q3 2021 | 28 holders, $11.9bn | 25 holders, $22.8bn |
| Q4 2021 | 28 holders, $14.7bn | 26 holders, $22.3bn |
| Q1 2022 | 25 holders, $14.4bn | 29 holders, $23.2bn |
| Q2 2022 | 30 holders, $13.5bn | 28 holders, $25.8bn |
| Q3 2022 | 28 holders, $13.9bn | 33 holders, $22.2bn |
| Q4 2022 | 30 holders, $12.6bn | 26 holders, $27.0bn |
| Q1 2023 | 36 holders, $9.6bn | 36 holders, $27.6bn |
| Q2 2023 | 33 holders, $9.8bn | 29 holders, $28.9bn |
| Q3 2023 | 33 holders, $11.7bn | 32 holders, $28.5bn |
| Q4 2023 | 32 holders, $14.2bn | 34 holders, $28.8bn |
| Q1 2024 | 21 holders, $14.3bn | 36 holders, $28.4bn |
| Q2 2024 | 24 holders, $14.2bn | 31 holders, $31.4bn |
| Q3 2024 | 31 holders, $14.2bn | 39 holders, $38.2bn |
| Q4 2024 | 32 holders, $11.0bn | 40 holders, $36.6bn |
| Q1 2025 | 29 holders, $19.1bn | 44 holders, $49.1bn |
| Q2 2025 | 31 holders, $19.6bn | 44 holders, $54.3bn |
| Q3 2025 | 28 holders, $21.9bn | 36 holders, $49.3bn |
| Q4 2025 | 29 holders, $22.8bn | 26 holders, $50.5bn |
| Q1 2026 | 32 holders, $21.1bn | 25 holders, $57.3bn |
| Q2 2026 | 31 holders, $30.8bn | 27 holders, $63.8bn |
CVS Health Corp
- Holders
- 28
- Reported value
- $21.9bn
- Buyers
- 16
- Sellers
- 11
Breadth +5 among 95 comparable managers.
Philip Morris Intl Inc
- Holders
- 36
- Reported value
- $49.3bn
- Buyers
- 20
- Sellers
- 15
Breadth +5 among 95 comparable managers.
Who holds both, Q3 2025
Both (18)
AllianceBernstein LP, AQR Capital Management LLC, Arrowstreet Capital LP, Bridgewater Associates LP, Capital Research Global Investors, Capital World Investors, D. E. Shaw & Co., Dodge & Cox, Fidelity (FMR LLC), Harris Associates LP, Invesco Ltd, Janus Henderson Group Ltd, Man Group PLC, Millennium Management LLC, T. Rowe Price Associates Inc, Walleye Capital LLC, Wellington Management Group LLP, Woodline Partners LP
Only CVS (10)
Citadel Advisors LLC, Freestone Grove Partners LP, GAMCO Investors Inc, Glenview Capital Management LLC, Holocene Advisors LP, Marshall Wace LLP, Moore Capital Management LP, Point72 Asset Management LP, Sachem Head Capital Management LP, Squarepoint Ops LLC
Only PM (18)
Acadian Asset Management LLC, Artisan Partners LP, Baillie Gifford & Co, Brevan Howard Capital Management LP, D1 Capital Partners LP, Eisler Capital Management Ltd, First Eagle Investment Management LLC, Lone Pine Capital LLC, Markel Group Inc, Maverick Capital Ltd, MFS Investment Management, Neuberger Berman Group LLC, Quantbot Technologies LP, Tudor Investment Corp, Two Sigma Advisers LP, Viking Global Investors LP, Voloridge Investment Management LLC, Winton Group Ltd
How much of the picture this is
A 13F is a manager’s long US-listed equity book at a quarter end, filed up to 45 days later. Buyers and sellers count comparable managers (those that filed both quarters) by shares, so a rise in value with no rise in shares is the price. Large books are listed to their largest positions. These are 95 tracked managers, not the institutional market.